INE794A01010
INE794A01010
NEULAND LABORATORIES LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 267.89B EUR | 239.03B EUR | 154.12B EUR | 194.91B EUR |
Enterprise Value | 270.13B EUR | 239.03B EUR | 156.37B EUR | 194.91B EUR |
Valuation Multiples | ||||
Trailing P/E | 53.82x | 48.02x | 42.34x | 128.8x |
Forward P/E | 43.02x | -- | -- | -- |
Price to Sales | 11.29x | 10.08x | 7.62x | 15.63x |
Price to Book | 14.29x | -- | 8.22x | -- |
EV/Revenue | 11.39x | 10.08x | 7.73x | 15.63x |
EV/EBITDA | 35.8x | 30.12x | 25.86x | 68.42x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |